PF4 and deep vein thrombosis: Furthermore, an investigation into a larger number of vaccinated individuals may be necessary to perform subgroup analyses in order to evaluate the possible role of confounding factors in the production of anti-PF4 antibodies and the presence of thrombosis following vaccination with the ChAdOx1 nCov-19 vaccine.